{"component": "clause", "props": {"groups": [{"snippet_links": [{"key": "the-planned", "type": "clause", "offset": [27, 38]}, {"key": "phase-iib-clinical-study", "type": "definition", "offset": [39, 63]}, {"key": "treatment-of", "type": "clause", "offset": [79, 91]}, {"key": "rheumatoid-arthritis", "type": "definition", "offset": [92, 112]}, {"key": "termination-of", "type": "definition", "offset": [139, 153]}], "size": 5, "snippet": "shall initiate and perform the planned Phase IIb Clinical Study of TRU-015 for treatment of rheumatoid arthritis through the completion or termination of such study; (", "samples": [{"hash": "iH6tgVVhJtu", "uri": "/contracts/iH6tgVVhJtu#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hlHc2DPcEBf", "uri": "/contracts/hlHc2DPcEBf#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hPIwhY9xfY4", "uri": "/contracts/hPIwhY9xfY4#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "61f313c16d90ced58c3663da1fe76e77", "id": 1}, {"snippet_links": [{"key": "continue-to-perform", "type": "clause", "offset": [6, 25]}, {"key": "development-activities", "type": "clause", "offset": [49, 71]}, {"key": "each-case", "type": "definition", "offset": [80, 89]}, {"key": "responsibilities-of", "type": "clause", "offset": [116, 135]}, {"key": "in-accordance-with", "type": "definition", "offset": [163, 181]}, {"key": "the-development-plan", "type": "clause", "offset": [182, 202]}, {"key": "clinical-studies", "type": "clause", "offset": [216, 232]}, {"key": "section-46", "type": "clause", "offset": [251, 262]}, {"key": "prior-to-completion", "type": "clause", "offset": [283, 302]}, {"key": "the-jdc", "type": "clause", "offset": [339, 346]}, {"key": "accurate-records", "type": "clause", "offset": [367, 383]}, {"key": "activities-under", "type": "clause", "offset": [406, 422]}, {"key": "with-applicable-laws", "type": "clause", "offset": [454, 474]}, {"key": "reasonable-request", "type": "definition", "offset": [485, 503]}, {"key": "access-to", "type": "definition", "offset": [530, 539]}, {"key": "period-of", "type": "definition", "offset": [596, 605]}, {"key": "calendar-year", "type": "clause", "offset": [652, 665]}, {"key": "responsible-for", "type": "clause", "offset": [747, 762]}, {"key": "clinical-trials", "type": "definition", "offset": [778, 793]}, {"key": "rheumatoid-arthritis", "type": "definition", "offset": [798, 818]}, {"key": "termination-of", "type": "definition", "offset": [883, 897]}, {"key": "internal-costs", "type": "clause", "offset": [1056, 1070]}, {"key": "costs-incurred", "type": "definition", "offset": [1160, 1174]}, {"key": "in-connection-with", "type": "clause", "offset": [1186, 1204]}, {"key": "the-foregoing", "type": "definition", "offset": [1205, 1218]}, {"key": "the-budget", "type": "definition", "offset": [1261, 1271]}, {"key": "contained-in", "type": "definition", "offset": [1272, 1284]}, {"key": "without-limitation", "type": "clause", "offset": [1328, 1346]}, {"key": "expenses-paid", "type": "clause", "offset": [1352, 1365]}, {"key": "contract-research", "type": "definition", "offset": [1381, 1398]}, {"key": "day-of", "type": "clause", "offset": [1502, 1508]}, {"key": "expense-category", "type": "definition", "offset": [1581, 1597]}, {"key": "accrual-basis", "type": "clause", "offset": [1605, 1618]}, {"key": "calendar-quarters", "type": "clause", "offset": [1744, 1761]}, {"key": "made-pursuant-to", "type": "clause", "offset": [1874, 1890]}, {"key": "submitted-by", "type": "definition", "offset": [1900, 1912]}, {"key": "with-respect-to", "type": "clause", "offset": [1954, 1969]}, {"key": "days-after", "type": "definition", "offset": [2101, 2111]}, {"key": "an-invoice", "type": "clause", "offset": [2132, 2142]}, {"key": "supporting-documentation", "type": "definition", "offset": [2193, 2217]}, {"key": "pocket-expenses", "type": "definition", "offset": [2298, 2313]}, {"key": "section-363", "type": "clause", "offset": [2334, 2347]}, {"key": "expenses-reimbursable", "type": "clause", "offset": [2367, 2388]}, {"key": "in-the-same-manner", "type": "definition", "offset": [2421, 2439]}, {"key": "section-361", "type": "clause", "offset": [2485, 2498]}], "size": 5, "snippet": "shall continue to perform the ongoing bioprocess development activities, and in each case (a-e) such activities and responsibilities of Trubion shall be performed in accordance with the Development Plan. None of the clinical studies described in this Section 4.6 shall be terminated prior to completion before discussion of such matter by the JDC. Trubion shall keep accurate records of its clinical study activities under this Section 4.6 in accordance with applicable laws and, upon reasonable request, shall provide Wyeth with access to such records. Trubion shall maintain such records for a period of at least three (3) years after the end of the calendar year in which they were generated. The Development Plan shall provide that Trubion is responsible for conducting the clinical trials for rheumatoid arthritis, *** and additional Niche Indications through the completion or termination of such clinical studies described above and shall contain a budget for such clinical trials. Trubion shall be solely responsible for its internal FTE and other internal costs for such Development activities, but Wyeth shall reimburse Trubion for all out-of-pocket costs incurred by Trubion in connection with the foregoing Development activities in accordance with the budget contained in the Development Plan (which shall include, without limitation, all expenses paid to one or more contract research organizations for such Development activities). Trubion shall provide to Wyeth, on or before the first day of each Calendar Quarter, a forecast of such out-of-pocket costs (by major expense category, on an accrual basis) reimbursable under this Section 4.6 that Trubion expects to incur during such Calendar Quarter and the subsequent three (3) Calendar Quarters, in each case shown by month. Reimbursement to be made to Trubion by Wyeth pursuant to this Section 4.6 will be made pursuant to invoices submitted by Trubion to Wyeth no more often than once with respect to any Calendar Quarter, within forty-five (45) days of the end of such Calendar Quarter. Payment shall be due within forty-five (45) days after Wyeth receives such an invoice from Trubion. Each invoice must be accompanied by supporting documentation sufficiently demonstrating the expense so incurred (such as receipts for out-of-pocket expenses). The provisions of Section 3.6.3 shall apply to the expenses reimbursable by Wyeth under this Section 4.6 in the same manner as they apply to expenses reimbursable under Section 3.6.1.", "samples": [{"hash": "hlHc2DPcEBf", "uri": "/contracts/hlHc2DPcEBf#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hPIwhY9xfY4", "uri": "/contracts/hPIwhY9xfY4#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "3HXHs8WznLr", "uri": "/contracts/3HXHs8WznLr#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "d05dd4f2842f0b56b0831b9e737c99e2", "id": 2}, {"snippet_links": [{"key": "defend-and-hold-harmless", "type": "clause", "offset": [16, 40]}, {"key": "directors-and", "type": "clause", "offset": [140, 153]}, {"key": "indemnified-party", "type": "definition", "offset": [177, 194]}, {"key": "pay-to", "type": "definition", "offset": [290, 296]}, {"key": "third-parties", "type": "clause", "offset": [309, 322]}, {"key": "resulting-from", "type": "definition", "offset": [323, 337]}, {"key": "arising-out-of", "type": "definition", "offset": [341, 355]}], "size": 4, "snippet": "will indemnify, defend and hold harmless Wyeth and its sublicensees, distributors and each of its and their respective employees, officers, directors and agents (each, a \"Wyeth Indemnified Party\") from and against any and all Liabilities that the Wyeth Indemnified Party may be required to pay to one or more Third Parties resulting from or arising out of:", "samples": [{"hash": "iH6tgVVhJtu", "uri": "/contracts/iH6tgVVhJtu#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hlHc2DPcEBf", "uri": "/contracts/hlHc2DPcEBf#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hPIwhY9xfY4", "uri": "/contracts/hPIwhY9xfY4#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "194babfd7e0ae96fbd6789db3786b923", "id": 3}, {"snippet_links": [{"key": "from-time-to-time", "type": "clause", "offset": [17, 34]}, {"key": "the-request", "type": "clause", "offset": [43, 54]}, {"key": "other-party", "type": "definition", "offset": [62, 73]}, {"key": "general-information", "type": "definition", "offset": [100, 119]}, {"key": "to-this-agreement", "type": "clause", "offset": [137, 154]}, {"key": "the-research-program", "type": "clause", "offset": [178, 198]}, {"key": "development-program", "type": "clause", "offset": [203, 222]}, {"key": "commercialization-of-licensed-products", "type": "clause", "offset": [276, 314]}, {"key": "publicly-disclosed", "type": "definition", "offset": [329, 347]}, {"key": "without-limitation", "type": "clause", "offset": [360, 378]}, {"key": "oral-presentation", "type": "definition", "offset": [419, 436]}], "size": 4, "snippet": "and Wyeth shall, from time to time, and at the request of the other Party, discuss and agree on the general information content relating to this Agreement (including relating to the Research Program and Development Program, and/or to research, Development, Manufacture and/or Commercialization of Licensed Products) which may be publicly disclosed (including, without limitation, by means of any printed publication or oral presentation).", "samples": [{"hash": "iH6tgVVhJtu", "uri": "/contracts/iH6tgVVhJtu#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hlHc2DPcEBf", "uri": "/contracts/hlHc2DPcEBf#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hPIwhY9xfY4", "uri": "/contracts/hPIwhY9xfY4#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "52321660b97f82432a988d9c6f588394", "id": 4}, {"snippet_links": [{"key": "as-of-the-effective-date", "type": "clause", "offset": [9, 33]}, {"key": "control-of", "type": "definition", "offset": [56, 66]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [75, 108]}, {"key": "patent-rights", "type": "definition", "offset": [159, 172]}, {"key": "signing-date", "type": "definition", "offset": [204, 216]}], "size": 4, "snippet": "Controls as of the Effective Date or that come into the Control of Trubion during the term of this Agreement and (b) claim any Trubion Know-How. Those Trubion Patent Rights known to be existing as of the Signing Date are listed on Exhibit 1.129 attached hereto.", "samples": [{"hash": "iH6tgVVhJtu", "uri": "/contracts/iH6tgVVhJtu#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hlHc2DPcEBf", "uri": "/contracts/hlHc2DPcEBf#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "hPIwhY9xfY4", "uri": "/contracts/hPIwhY9xfY4#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "b7d205be0860c4c274993c67cdbc12de", "id": 5}, {"snippet_links": [{"key": "promptly-notify", "type": "clause", "offset": [6, 21]}, {"key": "third-party-manufacturers", "type": "clause", "offset": [31, 56]}, {"key": "execution-of-this-agreement", "type": "clause", "offset": [60, 87]}, {"key": "to-extend", "type": "clause", "offset": [138, 147]}, {"key": "term-of", "type": "clause", "offset": [152, 159]}, {"key": "manufacturing-agreement", "type": "clause", "offset": [182, 205]}, {"key": "a-third-party", "type": "clause", "offset": [211, 224]}, {"key": "diligent-efforts", "type": "definition", "offset": [230, 246]}, {"key": "a-party", "type": "clause", "offset": [267, 274]}, {"key": "agreement-or", "type": "definition", "offset": [283, 295]}, {"key": "to-provide", "type": "definition", "offset": [296, 306]}, {"key": "third-party-beneficiary-rights", "type": "clause", "offset": [318, 348]}, {"key": "with-respect-to", "type": "clause", "offset": [349, 364]}, {"key": "assignment-of", "type": "definition", "offset": [397, 410]}, {"key": "applies-to", "type": "clause", "offset": [454, 464]}, {"key": "rights-and-obligations", "type": "definition", "offset": [515, 537]}, {"key": "to-the-extent", "type": "clause", "offset": [538, 551]}, {"key": "related-to", "type": "clause", "offset": [552, 562]}, {"key": "each-case", "type": "definition", "offset": [580, 589]}, {"key": "without-consent", "type": "definition", "offset": [612, 627]}], "size": 3, "snippet": "shall promptly notify existing Third Party manufacturers of execution of this Agreement, and, if Trubion proposes to materially amend, or to extend the term of, any existing Product manufacturing agreement with a Third Party, use Diligent Efforts to include Facet as a party to such agreement or to provide Facet with third party beneficiary rights with respect to such agreement and to allow for assignment of such agreement, or, if such agreement also applies to products that are not Products, assignment of all rights and obligations to the extent related to such Product, in each case from Trubion to Facet without consent from such Third Party manufacturer.", "samples": [{"hash": "dv1QK7B0aWi", "uri": "/contracts/dv1QK7B0aWi#trubion", "label": "Collaboration and License Agreement (Facet Biotech Corp)", "score": 21.2847364819, "published": true}, {"hash": "fXtvZWd168N", "uri": "/contracts/fXtvZWd168N#trubion", "label": "Collaboration and License Agreement (Trubion Pharmaceuticals, Inc)", "score": 21.0, "published": true}, {"hash": "6iuIA2dbSQg", "uri": "/contracts/6iuIA2dbSQg#trubion", "label": "Collaboration and License Agreement (Facet Biotech Corp)", "score": 21.0, "published": true}], "hash": "88fa516750be01e565f555de7b53a8fc", "id": 6}, {"snippet_links": [{"key": "in-compliance-with", "type": "definition", "offset": [3, 21]}, {"key": "applicable-legal-requirements", "type": "definition", "offset": [26, 55]}], "size": 3, "snippet": "is in compliance with all applicable Legal Requirements; and", "samples": [{"hash": "kdvG1XnBvVk", "uri": "/contracts/kdvG1XnBvVk#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "fUpO1Ssg9V9", "uri": "/contracts/fUpO1Ssg9V9#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "c8c1vM1PKv9", "uri": "/contracts/c8c1vM1PKv9#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "ecd20062cade9b03cff8c11fd87dedf5", "id": 7}, {"snippet_links": [{"key": "necessary-corporate-action", "type": "clause", "offset": [14, 40]}, {"key": "execution-and-delivery-of-this-agreement", "type": "clause", "offset": [58, 98]}, {"key": "the-performance", "type": "clause", "offset": [103, 118]}, {"key": "executed-and-delivered", "type": "clause", "offset": [178, 200]}, {"key": "on-behalf-of", "type": "clause", "offset": [201, 213]}, {"key": "binding-obligation", "type": "definition", "offset": [255, 273]}, {"key": "in-accordance-with", "type": "definition", "offset": [303, 321]}], "size": 3, "snippet": "has taken all necessary corporate action to authorize the execution and delivery of this Agreement and the performance of its obligations hereunder. This Agreement has been duly executed and delivered on behalf of Trubion, and constitutes a legal, valid, binding obligation, enforceable against Trubion in accordance with its terms; and", "samples": [{"hash": "kdvG1XnBvVk", "uri": "/contracts/kdvG1XnBvVk#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "fUpO1Ssg9V9", "uri": "/contracts/fUpO1Ssg9V9#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "c8c1vM1PKv9", "uri": "/contracts/c8c1vM1PKv9#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "a10e0e57585e9cec9efcfe2baf6c34ca", "id": 8}, {"snippet_links": [{"key": "authority-and", "type": "clause", "offset": [28, 41]}, {"key": "right-to-enter-into-this-agreement", "type": "clause", "offset": [52, 86]}], "size": 3, "snippet": "has the corporate power and authority and the legal right to enter into this Agreement and to perform its obligations hereunder;", "samples": [{"hash": "kdvG1XnBvVk", "uri": "/contracts/kdvG1XnBvVk#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "fUpO1Ssg9V9", "uri": "/contracts/fUpO1Ssg9V9#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "c8c1vM1PKv9", "uri": "/contracts/c8c1vM1PKv9#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "1a01b7931c7c05adda278bc68d730c9e", "id": 9}, {"snippet_links": [{"key": "the-product", "type": "clause", "offset": [18, 29]}, {"key": "accepted-by", "type": "definition", "offset": [44, 55]}, {"key": "the-fda", "type": "clause", "offset": [56, 63]}], "size": 3, "snippet": "files the BLA for the Product and it is not accepted by the FDA; or", "samples": [{"hash": "kdvG1XnBvVk", "uri": "/contracts/kdvG1XnBvVk#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "fUpO1Ssg9V9", "uri": "/contracts/fUpO1Ssg9V9#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}, {"hash": "c8c1vM1PKv9", "uri": "/contracts/c8c1vM1PKv9#trubion", "label": "Manufacturing Services Agreement (Trubion Pharmaceuticals, Inc)", "score": 18.0, "published": true}], "hash": "3b2b50cb7b033a75d5dbc009fc2e0e00", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhB0cnViaW9uIzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"parents": [["manufacturing", "Manufacturing"], ["roles-of-the-parties", "Roles of the Parties"], ["representations-and-warranties", "Representations and Warranties"], ["trubion", "Trubion"], ["term-termination", "Term Termination"]], "size": 11, "title": "Trubion", "children": [["trubion", "Trubion"]], "id": "trubion", "related": [["manufacturing-technology-transfer", "Manufacturing Technology Transfer", "Manufacturing Technology Transfer"], ["licensed-patent-rights", "Licensed Patent Rights", "Licensed Patent Rights"], ["collaboration", "Collaboration", "Collaboration"], ["licensed-patents", "Licensed Patents", "Licensed Patents"], ["licensee", "Licensee", "Licensee"]], "related_snippets": [], "updated": "2025-07-07T12:35:11+00:00"}, "json": true, "cursor": ""}}